Wong KK - Search Results

1

USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells.

Padmanabhan A, Candelaria N, Wong KK, Nikolai BC, Lonard DM, O'Malley BW, Richards JS. Padmanabhan A, et al. Among authors: wong kk. Nat Commun. 2018 Mar 28;9(1):1270. doi: 10.1038/s41467-018-03599-w. Nat Commun. 2018. PMID: 29593334 Free PMC article.

2

Wild-type tumor repressor protein 53 (Trp53) promotes ovarian cancer cell survival.

Mullany LK, Liu Z, King ER, Wong KK, Richards JS. Mullany LK, et al. Among authors: wong kk. Endocrinology. 2012 Apr;153(4):1638-48. doi: 10.1210/en.2011-2131. Epub 2012 Mar 6. Endocrinology. 2012. PMID: 22396451 Free PMC article.

3

Tumor repressor protein 53 and steroid hormones provide a new paradigm for ovarian cancer metastases.

Mullany LK, Liu Z, Wong KK, Deneke V, Ren YA, Herron A, Richards JS. Mullany LK, et al. Among authors: wong kk. Mol Endocrinol. 2014 Jan;28(1):127-37. doi: 10.1210/me.2013-1308. Epub 2013 Jan 1. Mol Endocrinol. 2014. PMID: 24264574 Free PMC article.

4

Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.

Leung CS, Yeung TL, Yip KP, Pradeep S, Balasubramanian L, Liu J, Wong KK, Mangala LS, Armaiz-Pena GN, Lopez-Berestein G, Sood AK, Birrer MJ, Mok SC. Leung CS, et al. Among authors: wong kk. Nat Commun. 2014 Oct 3;5:5092. doi: 10.1038/ncomms6092. Nat Commun. 2014. PMID: 25277212 Free PMC article.

5

Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian Carcinomas.

Crane EK, Kwan SY, Izaguirre DI, Tsang YT, Mullany LK, Zu Z, Richards JS, Gershenson DM, Wong KK. Crane EK, et al. Among authors: wong kk. PLoS One. 2015 Aug 6;10(8):e0135101. doi: 10.1371/journal.pone.0135101. eCollection 2015. PLoS One. 2015. PMID: 26248031 Free PMC article.

6

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival.

Mullany LK, Wong KK, Marciano DC, Katsonis P, King-Crane ER, Ren YA, Lichtarge O, Richards JS. Mullany LK, et al. Among authors: wong kk. Neoplasia. 2015 Oct;17(10):789-803. doi: 10.1016/j.neo.2015.10.003. Neoplasia. 2015. PMID: 26585234 Free PMC article.

7

Mutant p53 Promotes Epithelial Ovarian Cancer by Regulating Tumor Differentiation, Metastasis, and Responsiveness to Steroid Hormones.

Ren YA, Mullany LK, Liu Z, Herron AJ, Wong KK, Richards JS. Ren YA, et al. Among authors: wong kk. Cancer Res. 2016 Apr 15;76(8):2206-18. doi: 10.1158/0008-5472.CAN-15-1046. Epub 2016 Mar 10. Cancer Res. 2016. PMID: 26964623 Free PMC article.

8

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.

Au Yeung CL, Co NN, Tsuruga T, Yeung TL, Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, Schmandt R, Lu KH, Mok SC. Au Yeung CL, et al. Among authors: wong kk. Nat Commun. 2016 Mar 29;7:11150. doi: 10.1038/ncomms11150. Nat Commun. 2016. PMID: 27021436 Free PMC article.

9

Differences in gynecologic tumor development in Amhr2-Cre mice with KRAS^G12D or KRAS^G12V mutations.

Kun EHS, Tsang YTM, Lin S, Pan S, Medapalli T, Malpica A, Richards JS, Gershenson DM, Wong KK. Kun EHS, et al. Among authors: wong kk. Sci Rep. 2020 Nov 26;10(1):20678. doi: 10.1038/s41598-020-77666-y. Sci Rep. 2020. PMID: 33244099 Free PMC article.

10

Etiology and pathogenesis of epithelial ovarian cancer.

Mok SC, Kwong J, Welch WR, Samimi G, Ozbun L, Bonome T, Birrer MJ, Berkowitz RS, Wong KK. Mok SC, et al. Among authors: wong kk. Dis Markers. 2007;23(5-6):367-76. doi: 10.1155/2007/474320. Dis Markers. 2007. PMID: 18057520 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,821 results

Search Page

Filters